BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16000112)

  • 1. Studies of the efficacy of Enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against Yersinia enterocolitica serotype O3 in a cell culture system and in mice.
    Damasko C; Konietzny A; Kaspar H; Appel B; Dersch P; Strauch E
    J Vet Med B Infect Dis Vet Public Health; 2005 May; 52(4):171-9. PubMed ID: 16000112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains.
    Strauch E; Kaspar H; Schaudinn C; Dersch P; Madela K; Gewinner C; Hertwig S; Wecke J; Appel B
    Appl Environ Microbiol; 2001 Dec; 67(12):5634-42. PubMed ID: 11722917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of chosen bacteriophages on Yersinia enterocolitica strains.
    Kot B; Bukowski K; Jakubczak A; Kaczorek I
    Pol J Vet Sci; 2002; 5(1):47-50. PubMed ID: 11944586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of Yersinia enterocolitica strains isolated from swine and humans in Guipuzcoa].
    Pérez-Trallero E; Idígoras P; Solaun ML; Zigorraga C
    Enferm Infecc Microbiol Clin; 1992 Apr; 10(4):186-9. PubMed ID: 1606219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriocin-like antagonism in Yersinia enterocolitica.
    Csiszár K; Tóth I
    Acta Microbiol Hung; 1992; 39(2):193-201. PubMed ID: 1284897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of PCR fingerprinting to the differentiation of Yersinia enterocolitica strains isolated from humans and pigs.
    Kot B; Błaszczyk M
    Acta Microbiol Pol; 2003; 52(4):355-9. PubMed ID: 15095922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of Yersinia enterocolitica cells to inactivate bacteriophage I at 25 degrees and 37 degrees C.
    Calvo C; Brault J; Chalvignac MA; Ramos-Cormenzana A; Mollaret HH
    Microbios; 1986; 46(188-189):137-41. PubMed ID: 3747856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological data on pathogenic Yersinia enterocolitica in Southern Germany during 2000-2006.
    Bucher M; Meyer C; Grötzbach B; Wacheck S; Stolle A; Fredriksson-Ahomaa M
    Foodborne Pathog Dis; 2008 Jun; 5(3):273-80. PubMed ID: 18564908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of various Yersinia enterocolitica serotypes towards mice of Swiss and Balb/c strains.
    Zaremba M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):611-7. PubMed ID: 749814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of pathogenic Yersinia enterocolitica in pigs slaughtered at a Swiss abattoir.
    Fredriksson-Ahomaa M; Stolle A; Stephan R
    Int J Food Microbiol; 2007 Nov; 119(3):207-12. PubMed ID: 17727997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of enterocoliticin, a phage tail-like bacteriocin.
    Strauch E; Kaspar H; Schaudinn C; Damasko C; Konietzny A; Dersch P; Skurnik M; Appel B
    Adv Exp Med Biol; 2003; 529():249-51. PubMed ID: 12756766
    [No Abstract]   [Full Text] [Related]  

  • 12. The pathogenicity of Yersinia enterocolitica for piglets.
    Schiemann DA
    Can J Vet Res; 1988 Jul; 52(3):325-30. PubMed ID: 3167717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics.
    Frick JS; Fink K; Kahl F; Niemiec MJ; Quitadamo M; Schenk K; Autenrieth IB
    Infect Immun; 2007 Jul; 75(7):3490-7. PubMed ID: 17485456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriocin susceptibility of clinical Yersinia strains.
    Franzin L; Cabodi D; Fantino C
    Adv Exp Med Biol; 2003; 529():353-6. PubMed ID: 12756787
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of Yersinia enterocolitica biotype 1A strains of diverse origin with cultured cells in vitro.
    Singh I; Virdi JS
    Jpn J Infect Dis; 2005 Feb; 58(1):31-3. PubMed ID: 15728988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of Yersinia enterocolitica infections.
    Fredriksson-Ahomaa M; Stolle A; Korkeala H
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):315-29. PubMed ID: 16872368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of B cell response during Yersinia enterocolitica infection in resistant and susceptible strains of mice.
    Cangiani EE; Guiraldi FR; Pinto SE; de Medeiros BM
    Immunol Invest; 2007; 36(4):387-402. PubMed ID: 17691021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors of pathogenicity, biotype, serotype and antimicrobial sensitivity of 150 clinical isolates of Yersinia enterocolitica (1992-1994)].
    Gómez-Garcés JL; Wilhelmi I; Cogollos R; Alós JI; Páez M; Balas D; Arribi A; Delgado-Iribarren A
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):596-9. PubMed ID: 9053001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune responses differentiate infections with Brucella suis from Yersinia enterocolitica serotype O:9 in pigs.
    Riber U; Jungersen G
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):13-25. PubMed ID: 17270281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of Yersinia enterocolitica to non-cultured epithelial cells from pig and rabbit ilea.
    Hussein HM; Fenwick SG; Lumsden JS
    J Microbiol Methods; 2007 Feb; 68(2):424-6. PubMed ID: 17010460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.